Skip to main content

Table 1 TGF-β1, PDGF and proBNP levels in the whole study population

From: Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer

   Before RT After RT Three years    
n Md IQR Md IQR Md IQR p1 p2 p3
TGF-β1 (ng/ml) 63 19.2 (17.1–22.3) 18.8 (14.5–22.0) 17.2 (13.7–21.2) 0.003 0.001 0.101
PDGF (ng/ml) 63 15.4 (12.6–19.1) 13.8 (11.7–16.2) 15.6 (10.4–18.4) 0.001 0.046 0.661
proBNP (ng/l) 62 75.5 (42.5–125.5) 75.0 (35.5–132.8) 101.0 (55.5–183.3) 0.325 < 0.001 < 0.001
  1. TGF-β1 Transforming growth factor beta 1, PDGF Platelet-derived growth factor, proBNP N-terminal pro-brain natriuretic peptide, RT Radiotherapy, Md Median, IQR Interquartile range, p1 Change from before to after RT, p2 Change from before to 3 years after RT, p3 Change from after RT to 3 years after RT